Search

Your search keyword '"Scilipoti, Pietro"' showing total 17 results

Search Constraints

Start Over You searched for: Author "Scilipoti, Pietro" Remove constraint Author: "Scilipoti, Pietro" Publisher wolters kluwer uk Remove constraint Publisher: wolters kluwer uk
17 results on '"Scilipoti, Pietro"'

Search Results

1. PD61-04 LONG-TERM ONCOLOGICAL OUTCOMES OF SURGICALLY MANAGED VERY HIGH-RISK PROSTATE CANCER PATIENTS ACCORDING TO THE STAMPEDE TRIAL DEFINITION: IMPLICATIONS FOR THE SELECTION OF CANDIDATES FOR CLINICAL TRIALS.

2. PD41-10 UROLOGICAL FOLLOW-UP OF LYNCH SYNDROME: UTUC INCIDENCE AND MUTATIONAL PATTERNS IN A DEDICATED OUTPATIENT CLINIC.

3. MP77-11 NOMOGRAM PREDICTING OPTIMAL CANDIDATES FOR BLADDER-SPARING STRATEGIES AFTER NEOADJUVANT IMMUNOTHERAPY.

4. PD57-10 AGE-DEPENDENT EFFECT OF EARLY SALVAGE RADIOTHERAPY FOR BIOCHEMICAL RECURRENCE IN PROSTATE CANCER PATIENTS TREATED WITH RADICAL PROSTATECTOMY.

5. MP71-15 CANCER CONTROL RATES IN ADEQUATE VERSUS INADEQUATE TREATMENT WITH ADJUVANT IMMUNOTHERAPY INSTILLATIONS WITH BCG.

6. MP71-14 LONG TERM OUTCOMES OF LOW AND INTERMEDIATE RISK BLADDER CANCER PATIENTS TREATED WITH TRANSURETHRAL RESECTION ELIGIBLE FOR ACTIVE SURVEILLANCE.

7. MP71-10 HEAD-TO-HEAD ONCOLOGICAL OUTCOMES COMPARISON OF MITOMYCIN C VS BACILLUS CALMETTE-GUERIN TREATMENT IN INTERMEDIATE-RISK NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS.

8. MP71-07 THE IMPACT OF CENTRALIZED UROPATHOLOGY REVIEW IN THE MANAGEMENT OF BLADDER CANCER PATIENTS AT THE TIME OF TRANSURETHRAL RESECTION OF THE BLADDER.

9. PD45-05 WHEN DOES SYSTEMATIC BIOPSY INFORMATION MATTER THE MOST? IDENTIFYING INDEPENDENT PREDICTORS OF DISEASE DOWNGRADING AT RADICAL PROSTATECTOMY IN HIGH GRADE PROSTATE CANCER BASED ON A LARGE MULTI-INSTITUTIONAL SERIES.

10. MP53-18 IMPACT OF NEOADJUVANT CHEMO-IMMUNOTHERAPY ON INTRA AND POST OPERATIVE OUTCOMES IN PATIENTS WITH BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY AND PELVIC LYMPH NODE DISSECTION: PROSPECTIVE SURGICAL ASSESSMENT FROM THE NURE-COMBO TRIAL.

11. MP53-02 RISK OF NODE METASTASES IN MUSCLE INVASIVE BLADDER CANCER PATIENTS TREATED WITH NEOADJUVANT CHEMO- OR IMMUNOTHERAPY AND RADICAL CYSTECTOMY WITH BILATERAL PELVIC LYMPH NODE DISSECTION.

12. PD38-03 DETECTION OF LYMPH NODE INVOLVEMENT BEFORE RADICAL CYSTECTOMY: DIAGNOSTIC PERFORMANCE OF 18F-FDG PET/CT AND IMPLICATIONS IN THE THERAPEUTIC MANAGEMENT.

13. PD30-01 DEFINING INTERMEDIATE-RISK NON-MUSCLE INVASIVE BLADDER CANCER: A COMPARATIVE STUDY OF EAU AND IBCG CRITERIA.

14. MP37-20 THE EFFECT OF PENILE REHABILITATION AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY ON URINARY CONTINENCE AND ERECTILE FUNCTION RECOVERY. RESULTS FROM a HIGH-VOLUME, SINGLE-SURGEON SERIES.

15. MP16-11 LONG-TERM OUTCOMES OF PTA HIGH GRADE INTERMEDIATE AND HIGH RISK BLADDER CANCER PATIENTS.

16. MP14-11 THE ADDED VALUE OF CONCOMITANT WHOLE-PELVIS SALVAGE RADIATION THERAPY IN OLIGO-RECURRENT PROSTATE CANCER PATIENTS TREATED WITH METASTASIS-DIRECTED THERAPY FOR DISTANT POSITIVE UPTAKES AT PSMA PET.

17. MP05-20 WHOLE EXOME SEQUENCING ANALYSIS IN LOW-RISK PROSTATE CANCER PATIENTS WITH KNOWN FAMILY HISTORY. IMPLICATION FOR ACTIVE SURVEILLANCE.

Catalog

Books, media, physical & digital resources